Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 21,2018
"Anti-Evolution Drugs” Could Offer New Strategy against Antimicrobial Resistance Crisis
The battle between medicine and harmful bacteria has traditionally centered on the hunt for new antimicrobial drugs, but the pathogens almost inevitably develop resistance to every type of antibiotic developed. A team at the University of Washington (UW), Seattle, has now developed a new strategy that thwarts this ability to develop antimicrobial drug resistance (AMR)Read more
More
"Anti-Evolution Drugs” Could Offer New Strategy against Antimicrobial Resistance Crisis
Nov 21,2018
Medicilon Biomedicine's 15th Anniversary Series of Events Seminar on Innovative Drug Preclinical Research and Application-Nanjing
Medicilon will launch the 15th anniversary tour of "Hand in hand with you to help new drugs” nationwide. We invite you to witness our service capabilities in the field of new drug preclinical research and all our efforts in the development process, and to share and discuss the bits and pieces of new drug development.Read more
More
Medicilon Biomedicine's 15th Anniversary Series of Events Seminar on Innovative Drug Preclinical Research and Application-Nanjing
Nov 20,2018
Brown Fat Makes an Attractive Target for New Approaches to Treating Obesity
Scientists from Germany and Finland report that brown fat interacts with the gut hormone secretin in mice to relay nutritional signals about fullness to the brain during a meal. The study ("Secretin-Activated Brown Fat Mediates Prandial Thermogenesis to Induce Satiation”), published in Cell, reinforces our understanding of a long-suspected role of brown adipose tissue, a typeRead more
More
Nov 20,2018
Brain Cancer Spread Might Be Halted by Targeting Interstitial Fluid Flow
Scientists at Virginia Tech, led by Jennifer Munson, Ph.D., an assistant professor in the department of biomedical engineering and mechanics in the College of Engineering, say they may have found a solution to stopping the spread of glioblastoma. In an article ("Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model”) published in Scientific Reports,Read more
More
Brain Cancer Spread Might Be Halted by Targeting Interstitial Fluid Flow
Nov 19,2018
Life-Extending Alzheimer's Disease Candidates Identified from Diet Supplements
Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. Scientists at the Salk Institute have identified a new subclass of anti-aging geroprotector compounds that can slow aging in mice and could represent promising drug candidates for Alzheimer's disease (AD).Read more
More
Life-Extending Alzheimer's Disease Candidates Identified from Diet Supplements
Nov 19,2018
Conjugated Nanoparticles Improve Chemo Drug Delivery
Improving how chemotherapy is delivered to cancer cells is a major concern for researchers and drug manufacturers. One of the big issues with chemotherapy is that most treatment approaches focus on the tumor itself without paying significant attention to the microenvironment surrounding the tumor. Now, investigators at Purdue University have developed new technology aimed atRead more
More
Conjugated Nanoparticles Improve Chemo Drug Delivery
Nov 16,2018
Happy Thanksgiving 2018
  Thanksgiving is the time to say thanks to our valued partners, colleagues and friends. In this time of gratitude, we give thanks for you.  We value your patronage and appreciate your confidence in us. Counting you among our clients is something for which we are especially grateful. Medicilon wish you a very happy, warmRead more
More
Nov 16,2018
Norovirus Insights May Improve Conditions Below Deck
Outbreaks of norovirus in health care settings and outbreaks caused by a particular genotype of the virus are more likely to make people seriously ill, according to a new study ("The Norovirus Epidemiologic Triad: Predictors of Severe Outcomes in US Norovirus Outbreaks, 2009–2016”) by the Centers for Disease Control and Prevention (CDC) in The Journal of Infectious Diseases.Read more
More
Nov 16,2018
Herbal Folk Remedy Molecular Mechanisms Uncovered
Traditional herbal medicines used for centuries often have tangible physiologic and therapeutic value. Yet, for these remedies to be successful for the masses the underlying cellular and molecular properties need to be carefully teased out and assessed for safety and effectiveness. In that vein, investigators in the department of physiology & biophysics at the UniversityRead more
More
Nov 15,2018
Probiotic May Represent Bone-Boosting Therapy for Osteoporosis
A widely used probiotic stimulates bone formation in mice, and could feasibly represent a new approach to preventing or treating osteoporosis in human patients, according to research by Emory University researchers. Studies by Roberto Pacifici, Ph.D., and colleagues showed that in young, healthy female mice, treatment using Latobacillus rhamnosus GG (LGG) prompted other intestinal bacteria toRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->